HRP20010277B1 - Farmaceutski pripravak koji sadrži entakapon ili nitekapon kao i umreženi derivat celuloze - Google Patents

Farmaceutski pripravak koji sadrži entakapon ili nitekapon kao i umreženi derivat celuloze

Info

Publication number
HRP20010277B1
HRP20010277B1 HR20010277A HRP20010277A HRP20010277B1 HR P20010277 B1 HRP20010277 B1 HR P20010277B1 HR 20010277 A HR20010277 A HR 20010277A HR P20010277 A HRP20010277 A HR P20010277A HR P20010277 B1 HRP20010277 B1 HR P20010277B1
Authority
HR
Croatia
Prior art keywords
cellulose derivative
nitecapon
entacapon
pharmaceutical preparation
preparation containing
Prior art date
Application number
HR20010277A
Other languages
English (en)
Croatian (hr)
Inventor
Vahervuo Kari
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010277(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of HRP20010277A2 publication Critical patent/HRP20010277A2/hr
Publication of HRP20010277B1 publication Critical patent/HRP20010277B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HR20010277A 1998-09-14 1999-09-13 Farmaceutski pripravak koji sadrži entakapon ili nitekapon kao i umreženi derivat celuloze HRP20010277B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,263 US6599530B2 (en) 1998-09-14 1998-09-14 Oral compacted composition comprising catechol derivatives
PCT/FI1999/000740 WO2000015196A1 (en) 1998-09-14 1999-09-13 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Publications (2)

Publication Number Publication Date
HRP20010277A2 HRP20010277A2 (en) 2002-06-30
HRP20010277B1 true HRP20010277B1 (hr) 2010-10-31

Family

ID=22542186

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010277A HRP20010277B1 (hr) 1998-09-14 1999-09-13 Farmaceutski pripravak koji sadrži entakapon ili nitekapon kao i umreženi derivat celuloze

Country Status (39)

Country Link
US (1) US6599530B2 (cs)
EP (1) EP1112065B1 (cs)
JP (1) JP4619537B2 (cs)
KR (1) KR100732187B1 (cs)
CN (1) CN1151778C (cs)
AR (1) AR021806A1 (cs)
AT (1) ATE256454T1 (cs)
AU (1) AU746889B2 (cs)
BG (1) BG65041B1 (cs)
BR (1) BR9913681A (cs)
CA (1) CA2342634C (cs)
CO (1) CO5130008A1 (cs)
CZ (1) CZ293960B6 (cs)
DE (1) DE69913714T2 (cs)
DK (1) DK1112065T3 (cs)
EA (1) EA003282B1 (cs)
EE (1) EE04657B1 (cs)
ES (1) ES2213381T3 (cs)
GE (1) GEP20033062B (cs)
HK (1) HK1039750B (cs)
HR (1) HRP20010277B1 (cs)
HU (1) HU228910B1 (cs)
ID (1) ID29026A (cs)
IL (1) IL141681A0 (cs)
ME (1) ME00706B (cs)
MY (1) MY124394A (cs)
NO (1) NO331641B1 (cs)
NZ (1) NZ510583A (cs)
PE (1) PE20001060A1 (cs)
PL (1) PL193454B1 (cs)
PT (1) PT1112065E (cs)
RS (1) RS49723B (cs)
SI (1) SI1112065T1 (cs)
SK (1) SK284049B6 (cs)
TR (1) TR200100752T2 (cs)
TW (1) TWI222367B (cs)
UA (1) UA73925C2 (cs)
WO (1) WO2000015196A1 (cs)
ZA (1) ZA200102084B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US20060173074A1 (en) 2004-11-10 2006-08-03 Juha Ellmen Treatment of restless legs syndrome
AU2012216377C1 (en) * 2005-06-08 2013-10-10 Orion Corporation Oral dosage form
DK1896006T3 (da) * 2005-06-08 2009-12-07 Orion Corp Fremstillingmetode for entacapon-holdige granuler til orale doseringsformet
WO2007069274A2 (en) * 2005-11-09 2007-06-21 Torrent Pharmaceuticals Limited Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
JP2009527504A (ja) * 2006-02-23 2009-07-30 イオメディックス スリープ インターナショナル エスアールエル 良質な睡眠の誘導および維持のための組成物および方法
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
WO2007113371A1 (en) * 2006-03-31 2007-10-11 Iprbox Oy Pharmaceutical composition and preparation method thereof
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
JP5466179B2 (ja) * 2008-02-06 2014-04-09 ウォックハート リサーチ センター 生物学的利用能が改善されたエンタカポン、レボドパ及びカルビドパの医薬組成物
ATE534382T1 (de) 2008-02-06 2011-12-15 Wockhardt Ltd Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon
UA106877C2 (uk) * 2008-08-22 2014-10-27 Вокхардт Рісерч Сентер Фармацевтична композиція ентакапону або його солей пролонгованого вивільнення
EP2517704B1 (en) * 2009-12-25 2019-05-01 Innopharmax, Inc. Pharmaceutical composition for treating parkinson's disease and preparation method thereof
WO2012147099A1 (en) 2011-04-25 2012-11-01 Suven Nishtaa Pharma Pvt. Ltd. Pharmaceutical compositions of levodopa, carbidopa and entacapone
JP5855230B2 (ja) * 2011-04-26 2016-02-09 イノファーマックス インコーポレイテッド エンタカポン組成物
JP2018500300A (ja) 2014-11-28 2018-01-11 ノヴィファーマ，エス．アー． パーキンソン病を遅延させるための医薬
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3275433A1 (en) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Sustained release composition comprising micronized tolcapone
CN106236720A (zh) * 2016-08-29 2016-12-21 海南通用康力制药有限公司 一种恩他卡朋的药物组合物及其制备方法
CN113274362A (zh) * 2021-03-31 2021-08-20 海南通用康力制药有限公司 恩他卡朋片的生产方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives

Also Published As

Publication number Publication date
DE69913714T2 (de) 2004-10-07
PT1112065E (pt) 2004-04-30
ME00706B (me) 2007-12-31
TR200100752T2 (tr) 2001-10-22
BG65041B1 (bg) 2007-01-31
EA200100354A1 (ru) 2001-08-27
EP1112065A1 (en) 2001-07-04
GEP20033062B (en) 2003-09-25
HRP20010277A2 (en) 2002-06-30
EA003282B1 (ru) 2003-04-24
HU228910B1 (en) 2013-06-28
ATE256454T1 (de) 2004-01-15
CZ2001792A3 (cs) 2001-08-15
IL141681A0 (en) 2002-03-10
ZA200102084B (en) 2002-06-13
PE20001060A1 (es) 2000-10-20
DE69913714D1 (de) 2004-01-29
EE200100147A (et) 2002-06-17
ES2213381T3 (es) 2004-08-16
NO331641B1 (no) 2012-02-13
NO20011278D0 (no) 2001-03-13
UA73925C2 (uk) 2005-10-17
MY124394A (en) 2006-06-30
NZ510583A (en) 2002-09-27
SK3072001A3 (en) 2002-05-09
NO20011278L (no) 2001-03-13
KR100732187B1 (ko) 2007-06-27
JP2002524493A (ja) 2002-08-06
JP4619537B2 (ja) 2011-01-26
CA2342634C (en) 2008-01-29
YU19301A (sh) 2003-02-28
AU746889B2 (en) 2002-05-02
CO5130008A1 (es) 2002-02-27
HK1039750B (zh) 2005-02-18
HUP0103454A2 (hu) 2002-01-28
PL346618A1 (en) 2002-02-25
HUP0103454A3 (en) 2003-11-28
CN1319005A (zh) 2001-10-24
WO2000015196A1 (en) 2000-03-23
CA2342634A1 (en) 2000-03-23
ID29026A (id) 2001-07-26
BR9913681A (pt) 2001-06-05
CN1151778C (zh) 2004-06-02
RS49723B (sr) 2007-12-31
TWI222367B (en) 2004-10-21
PL193454B1 (pl) 2007-02-28
AR021806A1 (es) 2002-08-07
BG105436A (en) 2001-11-30
US20020132009A1 (en) 2002-09-19
SK284049B6 (sk) 2004-08-03
AU5748299A (en) 2000-04-03
HK1039750A1 (en) 2002-05-10
EP1112065B1 (en) 2003-12-17
SI1112065T1 (en) 2004-04-30
DK1112065T3 (da) 2004-04-05
CZ293960B6 (cs) 2004-08-18
US6599530B2 (en) 2003-07-29
EE04657B1 (et) 2006-08-15
KR20010075084A (ko) 2001-08-09

Similar Documents

Publication Publication Date Title
HRP20010277B1 (hr) Farmaceutski pripravak koji sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
IS1903B (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
DE69602638D1 (de) Naphthylverbindungen, Zwischenprodukte, Zusammensetzungen und Methoden
DK0817779T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
EE03692B1 (et) 19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
DK0876362T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
FI953898L (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
DK1095932T3 (da) Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
EE03767B1 (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
FI990134L (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
DK0820448T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
HUP0102400A3 (en) Substituted octalydropyrido[1,2a]pyrazin derivatives and pharmaceutical compositions containing the same
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FI953384L (fi) Uusi bentsolitiaditsiiniyhdiste, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset koostumukset
IL121969A0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them
NO20001288L (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmõte for fremstilling derav og anvendelse som legemiddel
FI973229L (fi) Uusi farmaseuttinen koostumus
TR199501082A2 (tr) Farmasötik formülasyonlar.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180910

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190913